deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT04787653

Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus

Sponsor: Otolith Labs

Conditions Tinnitus
Interventions Otoband Placebo
Updated 8 times since 2021 Last updated: Mar 21, 2022 Started: Mar 5, 2021 Primary completion: Jan 31, 2024 Completion: Feb 28, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Tinnitus, this trial is ongoing. The trial is conducted by Otolith Labs and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2021 – ~May 2021 · 30 days · monthly snapshotRecruiting~May 2021 – ~Jun 2021 · 31 days · monthly snapshotRecruiting~Jun 2021 – ~Apr 2022 · 10 months · monthly snapshotActive Not Recruiting~Apr 2022 – ~Apr 2024 · 24 months · monthly snapshotActive Not Recruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  4. Apr 2024 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  5. Apr 2022 — Apr 2024 [monthly]

    Active Not Recruiting NA

Show 3 earlier versions
  1. Jun 2021 — Apr 2022 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  2. May 2021 — Jun 2021 [monthly]

    Recruiting NA

  3. Apr 2021 — May 2021 [monthly]

    Recruiting NA

    First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Otolith Labs
Data source: Otolith Labs

For direct contact, visit the study record on ClinicalTrials.gov .